• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

父母非酒精性脂肪肝疾病会增加后代非酒精性脂肪肝疾病的风险。

Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring.

机构信息

Section of Gastroenterology, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts.

Department of Biostatistics, Boston University, Boston, Massachusetts.

出版信息

Liver Int. 2019 Apr;39(4):740-747. doi: 10.1111/liv.13956. Epub 2018 Sep 25.

DOI:10.1111/liv.13956
PMID:30179294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6758911/
Abstract

BACKGROUND & AIMS: Little is known regarding the risk of hepatic steatosis (HS) among adult children of affected parents. We examined the association between parental and offspring HS in the multigenerational Framingham Heart Study, which characterized HS using computed tomography.

METHODS

We performed multivariable logistic regression models adjusted for age, sex, alcohol use, and body mass index to generate the odds of HS according to parental HS. We determined the proportion of participants with HS according to parental HS and the presence or absence of hypertension, diabetes, or obesity (BMI ≥30 kg/m ). After excluding heavy alcohol use (n = 126) and missing covariates (n = 1), 785 offspring with at least one parent were included.

RESULTS

Approximately 23% (183/785) had at least one parent with HS and 1.1% had two affected parents (9/785). In adjusted models, participants with at least one parent with HS had a nearly two-fold increased odds of HS compared to participants without a parental history of HS (OR 1.86, 95% confidence interval 1.15-3.03). Among participants without hypertension, diabetes, or obesity, a higher proportion had HS if they had a parental history of HS compared to those without (16.1% vs 5.2%, P < 0.001). However, for participants with cardiometabolic risk factors, we did not observe a difference in HS among those with and without parental HS (30.3% vs 28.5%, P = 0.78).

CONCLUSIONS

Individuals with a parental history of HS are at increased risk for HS. Specifically, a parental history of HS may be an important factor among those that are otherwise metabolically healthy.

摘要

背景与目的

人们对父母患病子女患肝脂肪变性(HS)的风险知之甚少。我们通过使用计算机断层扫描(CT)对 HS 进行特征描述,在 Framingham 心脏研究的多代人群中研究了父母与子女 HS 之间的关联。

方法

我们采用多变量逻辑回归模型,根据父母的 HS 情况调整年龄、性别、饮酒和体重指数(BMI),以生成 HS 的比值比(OR)。我们根据父母的 HS 情况和是否存在高血压、糖尿病或肥胖症(BMI≥30kg/m )确定 HS 患者的比例。排除大量饮酒(n=126)和缺失的协变量(n=1)后,纳入 785 名至少有一名父母的子女。

结果

大约 23%(183/785)的子女至少有一位父母患有 HS,1.1%的子女有两位患病父母(9/785)。在调整后的模型中,与没有父母 HS 史的参与者相比,至少有一位父母患有 HS 的参与者发生 HS 的几率增加近两倍(OR 1.86,95%置信区间 1.15-3.03)。在没有高血压、糖尿病或肥胖症的参与者中,与没有父母 HS 史的参与者相比,有父母 HS 史的参与者 HS 发生率更高(16.1%比 5.2%,P<0.001)。然而,对于存在心血管代谢危险因素的参与者,我们没有观察到父母 HS 史对 HS 发生率的影响存在差异(30.3%比 28.5%,P=0.78)。

结论

有父母 HS 史的个体发生 HS 的风险增加。具体来说,父母 HS 史可能是那些代谢健康的个体中一个重要的因素。

相似文献

1
Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring.父母非酒精性脂肪肝疾病会增加后代非酒精性脂肪肝疾病的风险。
Liver Int. 2019 Apr;39(4):740-747. doi: 10.1111/liv.13956. Epub 2018 Sep 25.
2
Relations of Liver Fat With Prevalent and Incident Atrial Fibrillation in the Framingham Heart Study.弗明汉心脏研究中肝脏脂肪与心房颤动患病率及发病率的关系
J Am Heart Assoc. 2017 May 2;6(5):e005227. doi: 10.1161/JAHA.116.005227.
3
Association of parental obesity with concentrations of select systemic biomarkers in nonobese offspring: the Framingham Heart Study.父母肥胖与非肥胖后代中特定全身生物标志物浓度的关联:弗雷明汉心脏研究
Diabetes. 2009 Jan;58(1):134-7. doi: 10.2337/db08-0918. Epub 2008 Oct 17.
4
Sex differences between parental pregnancy characteristics and nonalcoholic fatty liver disease in adolescents.父母妊娠特征与青少年非酒精性脂肪性肝病的性别差异。
Hepatology. 2018 Jan;67(1):108-122. doi: 10.1002/hep.29347. Epub 2017 Nov 13.
5
Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study.基于前瞻性双胞胎研究的肝纤维化和脂肪变性的遗传性。
Gastroenterology. 2015 Dec;149(7):1784-93. doi: 10.1053/j.gastro.2015.08.011. Epub 2015 Aug 20.
6
The immunity-related GTPase M rs13361189 variant does not increase the risk for prevalent or incident steatosis; results from the Framingham Heart Study.免疫相关 GTPase M rs13361189 变异与现患或新发脂肪变性风险无关:弗雷明汉心脏研究结果。
Liver Int. 2019 Jun;39(6):1022-1026. doi: 10.1111/liv.14039. Epub 2019 Feb 17.
7
Association between non-alcoholic hepatic steatosis and hyper reactive blood pressure response on the exercise treadmill test.非酒精性肝脂肪变性与运动平板试验中高反应性血压反应之间的关联。
QJM. 2016 Aug;109(8):531-7. doi: 10.1093/qjmed/hcw003. Epub 2016 Jan 19.
8
The association of non-alcoholic fatty liver disease between parents and adolescent children.父母与青少年子女之间非酒精性脂肪性肝病的相关性。
Aliment Pharmacol Ther. 2023 Jan;57(2):245-252. doi: 10.1111/apt.17257. Epub 2022 Oct 21.
9
Depression and increased risk of non-alcoholic fatty liver disease in individuals with obesity.肥胖人群的抑郁与非酒精性脂肪性肝病风险增加。
Epidemiol Psychiatr Sci. 2021 Mar 12;30:e23. doi: 10.1017/S204579602000116X.
10
The common PNPLA3 variant p.I148M is associated with liver fat contents as quantified by controlled attenuation parameter (CAP).常见的PNPLA3变体p.I148M与通过受控衰减参数(CAP)量化的肝脏脂肪含量相关。
Liver Int. 2016 Mar;36(3):418-26. doi: 10.1111/liv.12937. Epub 2015 Oct 3.

引用本文的文献

1
The effects of weight loss interventions on children and adolescents with non-alcoholic fatty liver disease: A systematic review and meta-analysis.减肥干预措施对非酒精性脂肪性肝病儿童及青少年的影响:一项系统评价与荟萃分析。
Obes Sci Pract. 2024 Apr 26;10(3):e758. doi: 10.1002/osp4.758. eCollection 2024 Jun.
2
The contribution of genetics and epigenetics to MAFLD susceptibility.遗传学和表观遗传学对 MAFLD 易感性的贡献。
Hepatol Int. 2024 Oct;18(Suppl 2):848-860. doi: 10.1007/s12072-024-10667-5. Epub 2024 Apr 25.
3
Maternal gestational hypertension, smoking and pre-eclampsia are associated with metabolic dysfunction-associated fatty liver disease in overweight offspring.

本文引用的文献

1
Genetics of alcoholic liver disease and non-alcoholic steatohepatitis.酒精性肝病和非酒精性脂肪性肝炎的遗传学。
Clin Med (Lond). 2018 Apr 1;18(Suppl 2):s54-s59. doi: 10.7861/clinmedicine.18-2-s54.
2
Improved Diet Quality Associates With Reduction in Liver Fat, Particularly in Individuals With High Genetic Risk Scores for Nonalcoholic Fatty Liver Disease.改善饮食质量与肝内脂肪减少相关,尤其在非酒精性脂肪性肝病遗传风险评分较高的个体中。
Gastroenterology. 2018 Jul;155(1):107-117. doi: 10.1053/j.gastro.2018.03.038. Epub 2018 Mar 29.
3
Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis.
母体妊娠期高血压、吸烟和子痫前期与超重后代代谢功能障碍相关脂肪性肝病有关。
Acta Obstet Gynecol Scand. 2024 Jun;103(6):1183-1191. doi: 10.1111/aogs.14816. Epub 2024 Mar 3.
4
Parental History of Type 2 Diabetes Mellitus and PNPLA3 Polymorphism Increase the Risk of Severe Stages of Nonalcoholic Fatty Liver Disease.2型糖尿病家族史和PNPLA3基因多态性增加非酒精性脂肪性肝病严重阶段的风险。
Dig Dis Sci. 2024 Feb;69(2):634-642. doi: 10.1007/s10620-023-08214-7. Epub 2023 Dec 19.
5
Parental metabolic syndrome and elevated liver transaminases are risk factors for offspring, even in children and adolescents with a normal body mass index.父母代谢综合征和肝转氨酶升高是子代的危险因素,即使在体重指数正常的儿童和青少年中也是如此。
Front Nutr. 2023 Oct 24;10:1166244. doi: 10.3389/fnut.2023.1166244. eCollection 2023.
6
Development and Validation of the Nonalcoholic Fatty Liver Disease Familial Risk Score to Detect Advanced Fibrosis: A Prospective, Multicenter Study.非酒精性脂肪性肝病家族风险评分检测肝纤维化进展的开发和验证:一项前瞻性、多中心研究。
Clin Gastroenterol Hepatol. 2024 Jan;22(1):81-90.e4. doi: 10.1016/j.cgh.2023.06.020. Epub 2023 Jul 3.
7
Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者一级亲属发生肝纤维化的风险。
J Clin Invest. 2022 Nov 1;132(21):e162513. doi: 10.1172/JCI162513.
8
Effect of cofactors on NAFLD/NASH and MAFLD. A paradigm illustrating the pathomechanics of organ dysfunction.辅助因子对非酒精性脂肪性肝病/非酒精性脂肪性肝炎及代谢相关脂肪性肝病的影响。一种阐释器官功能障碍病理机制的范例。
Metab Target Organ Damage. 2022;2(3). doi: 10.20517/mtod.2022.14. Epub 2022 Aug 22.
9
Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring.非酒精性脂肪性肝病及其遗传、表观遗传和环境因素对子代的影响。
World J Gastroenterol. 2022 Jul 7;28(25):2890-2899. doi: 10.3748/wjg.v28.i25.2890.
10
Factors early in life associated with hepatic steatosis.生命早期与肝脂肪变性相关的因素。
World J Hepatol. 2022 Jun 27;14(6):1235-1247. doi: 10.4254/wjh.v14.i6.1235.
伴有肝硬化的非酒精性脂肪性肝病会增加家族性晚期纤维化风险。
J Clin Invest. 2017 Jun 30;127(7):2697-2704. doi: 10.1172/JCI93465. Epub 2017 Jun 19.
4
Epigenetics and Liver Fibrosis.表观遗传学与肝纤维化
Cell Mol Gastroenterol Hepatol. 2017 Apr 26;4(1):125-134. doi: 10.1016/j.jcmgh.2017.04.007. eCollection 2017 Jul.
5
Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study.肝脂肪变性与肝纤维化之间的共同遗传效应:一项前瞻性双生子研究。
Hepatology. 2016 Nov;64(5):1547-1558. doi: 10.1002/hep.28674. Epub 2016 Jul 25.
6
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.MBOAT7-TMC4基因变异rs641738增加欧洲裔个体患非酒精性脂肪性肝病的风险。
Gastroenterology. 2016 May;150(5):1219-1230.e6. doi: 10.1053/j.gastro.2016.01.032. Epub 2016 Feb 2.
7
Hepatic stellate cell transdifferentiation involves genome-wide remodeling of the DNA methylation landscape.肝星状细胞转分化涉及DNA甲基化图谱的全基因组重塑。
J Hepatol. 2016 Mar;64(3):661-73. doi: 10.1016/j.jhep.2015.11.024. Epub 2015 Nov 26.
8
Non-alcoholic fatty liver disease and risk of cardiovascular disease.非酒精性脂肪性肝病与心血管疾病风险
Metabolism. 2016 Aug;65(8):1136-50. doi: 10.1016/j.metabol.2015.09.017. Epub 2015 Sep 25.
9
Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: A multiethnic study.TM6SF2基因rs58542926位点在非酒精性小儿脂肪肝发病机制中的作用:一项多民族研究。
Hepatology. 2016 Jan;63(1):117-25. doi: 10.1002/hep.28283. Epub 2015 Nov 16.
10
The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2.非酒精性脂肪性肝病的遗传学:聚焦于PNPLA3和TM6SF2。
Semin Liver Dis. 2015 Aug;35(3):270-90. doi: 10.1055/s-0035-1562947. Epub 2015 Sep 17.